Regeneron Pharmaceuticals (REGN) Q1 2021 Earnings

5FebConfirmed
Q2 2020
Q3 2020
Q4 2020
Q1 2021
5.73
7
8.26
9.53

Details

Expected EPS
8.7
Actual EPS
9.53
Surprise EPS
0.83
Surprise Percent
+9.54%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 9.53 per share for Q1 2021.

0 Comments

Share your thoughts